Holen Sie sich die Stockscreener-App
0.1515
2.49%
0.0028
Azitra Inc Aktie (AZTR) Neueste Nachrichten
Why Is AZTR Stock Rising Today? - Stocktwits
Azitra Inc Actuals & Estimates (AMEX:AZTR) - TradingView
Dauntless Investment Group buys stake in Azitra (AZTR) — 9.58% disclosed - Stock Titan
AZTR Forecast — Price Target — Prediction for 2027 - TradingView
Francisco D. Salva Discloses Investment at Azitra, Inc. with 9.99% Stake - TradingView
$Azitra (AZTR.US)$ - Moomoo
[SCHEDULE 13D] Azitra, Inc. Major Shareholder Acquisition (>5%) - Stock Titan
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket - Sahm
Azitra Inc (AZTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Form 13G Azitra For: 22 June By Investing.com - Investing.com Australia
Stonepine group discloses 1.74M-share stake in Azitra (NASDAQ: AZTR) with 9.9% cap - Stock Titan
$Azitra (AZTR.US)$ tq aztr - Moomoo
Why Did Azitra (AZTR) Stock Jump Over 25% After Hours? - Benzinga
Azitra Inc (AZTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Azitra (AZTR) CEO converts Series A preferred stock into common shares - Stock Titan
cant predict the pullback bottom. but you can predict the real buy and real sell zones based off market structure - Moomoo
AZTR Q1 2026 Earnings: Significant EPS Miss as Company Continues Pre-Revenue StageEPS Miss Report - dars.gov.et
Azitra Inc (AZTR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Azitra Inc (AZTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Azitra Inc (AZTR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Recently, the CEO of Azitra Inc issued an open letter to shareholders, detailing the company's current strategic adjustments and providing an outlook on development prospects for 2026 and beyond. - Bitget
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strateg - GuruFocus
Azitra, Inc. Unveils Strategic Shift: New Cosmetic Ingredient Program and Biotech Expansion Set for 2026 Growth - Minichart
Azitra Announces Strategic Shift Toward Cosmetics and Biotech Tools - TipRanks
Azitra CEO outlines strategic reorientation, $10.5M financing, ATR-COSF and recombinant protein initiatives - TradingView
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond - PR Newswire
Azitra's Pivot: From Pharma Pipeline to Biotech Platform - BriefGlance
Azitra Expands Authorized Shares Following Stockholder Approvals - TipRanks
Azitra Inc (AZTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Azitra Inc (AZTR) Institutional Confidence - TradingKey
Azitra Inc (AZTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Azitra, Inc. to Present at 2026 BIO International Convention - PR Newswire
Azitra's Big Gamble: From Rare Disease Cures to the Beauty Counter - BriefGlance
Azitra shareholders approve share increase and board proposals at annual meeting - Investing.com UK
Azitra, Inc. Files Form 8-K: Amendment to Certificate of Incorporation and Key Company Details (June 2026) - Minichart
Azitra shareholders approve share increase and board proposals at annual meeting By Investing.com - Investing.com South Africa
Azitra (NYSE: AZTR) wins votes for share increase and financing issuances - Stock Titan
AZTR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock DeclinesEarnings Yield Analysis - newsline.com
AZTR Q1 2026 Earnings: Massive EPS Miss Highlights Operational ChallengesAnnual Financial Report - newsline.com
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Bu - GuruFocus
Azitra Adjourns 2026 Annual Meeting for Lack of Quorum - The Globe and Mail
Azitra (AZTR) delays 2026 annual meeting after low shareholder turnout - Stock Titan
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting - Nasdaq
[EFFECT] Azitra, Inc. SEC Filing - Stock Titan
Azitra Inc (AZTR) Slips 5% as Stock Tests Key Support Near $0.21Leveraged ETF Flow - newsline.com
Azitra Inc (AZTR) Surges 12%: Small-Cap Biotech Breaks Above SupportHead and Shoulders - thelegaladvocate.com
Azitra Inc Q1 2026 Earnings: EPS Misses Estimates by Wide Margin; Stock Surges Amid No Revenue Reported - The Legal Advocate
1.26%
3.59%
Kapitalisierung:
|
Volumen (24h):